Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Unlock ways to earn travel points on no fee cards. Boost your rewards and make the most of your travel expenses effortlessly.
17,323 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Pony AI reports unit-level profitability in Guangzhou but faces a long road to company-wide profits as it scales flee...
New data reveals a recurring pattern: bitcoin traders dump coins in the 48 hours after FED policy decisions, marking ...
New York’s 2025 bonuses hit an all-time high, with payouts topping $49.2 billion and the average near $247k. Yet the ...
Kick off your day with ten concise investing reads tailored for Thursday mornings. From market trends to AI disruptio...
As Rex gears up to report Q4 2025 results, investors should focus on growth drivers, margins, and the outlook. This g...
What looks like a bargain today could turn into a meaningful gain by 2026. This guide shows how patient investors ide...
Wells Fargo cuts Gartner's price target to $140 as macro volatility tied to geopolitical tensions and AI competition ...
Serve Robotics has faced a meaningful pullback, but a closer look at its partnerships, deployment plans, and unit eco...
A caller facing a $7,000 IRS bill on The Ramsey Show was urged to pay immediately to avoid steep penalties and daily-...
A tiny pre-IPO tech winner is closing its round for retail investors as millions log hours in VR workspaces. Here’s w...
A rare macro diamond pattern on XRP draws attention as traders weigh a potential long-range breakout. Analysts stress...